Grand Pharmaceutical Group Ltd 00512
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 4.05
- Day Range
- HKD 4.04–4.30
- 52-Week Range
- HKD 3.17–5.40
- Bid/Ask
- HKD 4.26 / HKD 4.27
- Market Cap
- HKD 14.92 Bil
- Volume/Avg
- 5.5 Mil / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 8.14
- Price/Sales
- 1.42
- Dividend Yield (Trailing)
- 3.29%
- Dividend Yield (Forward)
- 6.10%
- Total Yield
- 3.83%
Company Profile
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 10,534
- Website
- http://www.chinagrandpharm.com
Comparables
Valuation
|
Metric
|
00512
|
00570
|
600976
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.14 | 17.81 | 19.60 |
Price/Book Value | 0.98 | 0.93 | 3.86 |
Price/Sales | 1.42 | 1.08 | 2.05 |
Price/Cash Flow | 5.48 | 473.28 | 22.88 |
Price/Earnings
00512
00570
600976
Financial Strength
|
Metric
|
00512
|
00570
|
600976
|
|---|---|---|---|
Quick Ratio | 0.81 | 1.33 | 1.17 |
Current Ratio | 1.08 | 1.93 | 1.49 |
Interest Coverage | 16.50 | 5.42 | 154.40 |
Quick Ratio
00512
00570
600976
Profitability
|
Metric
|
00512
|
00570
|
600976
|
|---|---|---|---|
Return on Assets (Normalized) | 11.38% | 2.98% | 11.61% |
Return on Equity (Normalized) | 17.95% | 5.52% | 21.54% |
Return on Invested Capital (Normalized) | 14.61% | 4.23% | 20.42% |
Return on Assets
00512
00570
600976
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ywktknypn | Vrqwch | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Ttvpdplcdn | Wjpf | $68.9 Bil | |
HLN
| Haleon PLC ADR | Hkhygqnk | Kdl | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zftqtfj | Rqs | $14.7 Bil | |
VTRS
| Viatris Inc | Qnmqcffy | Lytr | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mxshcsd | Lwlz | $11.9 Bil | |
CTLT
| Catalent Inc | Zsdljdzqq | Swddt | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rnmqwfjsg | Rcbq | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xhsxnhy | Cnz | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dwthrypn | Hrnjg | $3.5 Bil |